Ajinomoto expands in bio with Althea acquisition
March 11, 2013Manufacturing and Production Ajinomoto, althea
Japanese drugmaker Ajinomoto has agreed to acquire Althea Technologies, a provider of biopharmaceutical development and manufacturing services, for an estimated …
Contract research news in brief
March 11, 2013Research and Development Accelovance, BioLamina, Clinstar LLC, Critical Path Services, PRA, PSI CRO, Radiant Development, Roche, Synta
Consolidation news in the CRO sector as Accelovance buys Radiant and PRA snaps up Clinstar, plus updates from Roche/BioLamina, PSI …
Pharma manufacturing news in brief
March 11, 2013Business Services, Manufacturing and Production Actavis, DSM, Eisai, J&J, JJ, Marken, SAFC, Sagent Pharma
Actavis revises supply deal with Sagent, facility updates from Marken and SAFC, a supply deal for DSM plus another J&J …
Growth for Merck KGaA
March 8, 2013Research and Development
2012 saw German firm’s pharma division helping drive strong sales. Pharma revenue helped drive growth at Merck KGaA last year, with …
GSK files albiglutide in EU
March 8, 2013Research and Development
GlaxoSmithKline has filed its investigational, long-acting diabetes drug albiglutide with the European Medicines Agency.The GLP-1 receptor agonist, which will take …
ABPI supply chain warning
March 7, 2013Manufacturing and Production, Sales and Marketing ABPI, API, EFPIA
The ABPI is warning of supply chain problems which may cause a bottleneck in UK pharma manufacture this summer. The …
Perjeta approved in EU
March 7, 2013Sales and Marketing Perjeta, Roche
Roche’s oncology brand Perjeta has been approved in Europe to treat patients with an aggressive form of breast cancer. The …
New developer for Life Healthcare Communications
March 6, 2013Medical Communications, Sales and Marketing Life healthcare communications
Life Healthcare Communications has expanded its digital department with the appointment of senior software developer Adam Richardson. Richardson brings over …
Glide Pharma appoints chief executive
March 6, 2013Manufacturing and Production, Research and Development, Sales and Marketing Glide Pharma
Life sciences development and device firm Glide Pharma has announced the appointment of Dr Mark Carnegie-Brown as its chief executive. …
Government changes tender regulations
March 6, 2013Sales and Marketing GPs, NHS, coalition
The government has agreed to alter a key part of the Health and Social Care Act after GPs protested about …
UK lag in early deaths
March 5, 2013Medical Communications, Sales and Marketing Gates, Lancet, UK
The UK is lagging behind other developed nations when it comes to preventing early deaths from a number of diseases, …
Hospira woes continue as GSK sues over quality failures
March 5, 2013Manufacturing and Production GSK, Hospira
The difficulties besetting generic firm and contract manufacturer Hospira have taken a new turn with the news that one of …
Nicholson faces down critics
March 5, 2013Medical Communications, Sales and Marketing Mid Staffs, NHS, Nicholson
Sir David Nicholson, chief executive of the NHS, has been involved in testy exchanges with MPs at the House of …
Capsugel cuts deal to buy Scotland’s Encap
March 5, 2013Manufacturing and Production Capsugel, encap
Capsugel has bought Scotland’s Encap Drug Delivery in yet another bout of merger & acquisition (M&A) activity in the capsule …
NHS Commissioning Board appoints new director of Patient Experience
March 4, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CB, Churchill, NHS, UK
The NHS Commissioning Board has appointed Neil Churchill as the director of Patient Experience. In this new role Churchill will ensure that improving patient …
IPEC Americas takes aim at atypical visible particles
March 4, 2013Manufacturing and Production AVP, IPEC Americas
The industry body representing excipient users and suppliers in the US has set up a working group to tackle the …
Risk-assessment for excipients: guideline out for comment
March 4, 2013Manufacturing and Production GMP, risk
The European Commission has published its long-awaited risk-assessment guideline for determining the level of Good Manufacturing Practice (GMP) needed for …
EU approval for Ilaris
March 4, 2013Sales and Marketing Ilaris, Novartis
Novartis’ Ilaris has become the first biologic approved by the European Commission to treat patients suffering acute gouty arthritis attacks …
Zaltrap launched in UK
March 4, 2013Sales and Marketing Sanofi, Zaltrap
Sanofi and Regeneron Pharmaceuticals’ bowel cancer drug Zaltrap has been launched in the UK today. Zaltrap (aflibercept) will be used …
Boehringer targets AML
March 1, 2013Research and Development, Sales and Marketing AML, Boehringer
Boehringer Ingelheim is to begin a pivotal trial of its investigative treatment volasertib in patients with acute myeloid leukaemia (AML). …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
